Literature DB >> 7061364

In-vitro activity of Sch 29482 in comparison with other oral antibiotics.

G M Eliopoulos, A Gardella, R C Moellering.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7061364     DOI： 10.1093/jac/9.suppl_c.143

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.

Authors:  H W Boucher; C B Wennersten; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound.

Authors:  J S Daly; G M Eliopoulos; S Willey; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  In vitro evaluation of the new paulomycin antibiotic paldimycin.

Authors:  G M Eliopoulos; E Reiszner; R C Moellering
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

4.  In vitro activity of BMY-28100, a new oral cephalosporin.

Authors:  G M Eliopoulos; E Reiszner; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

5.  Comparative in vitro antibacterial activity of Sch 34343, a novel penem antibiotic.

Authors:  S R Norrby; M Jonsson
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

6.  In vitro activities of two glycylcyclines against gram-positive bacteria.

Authors:  G M Eliopoulos; C B Wennersten; G Cole; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.

Authors:  G M Eliopoulos; K Klimm; C T Eliopoulos; M J Ferraro; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

8.  In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; C Thauvin; B Gerson; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

10.  In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.